|By PR Newswire||
|February 12, 2014 09:48 AM EST||
AMSTERDAM, February 12, 2014 /PRNewswire/ --
Breakthrough for people with acne, eczema, rosacea and skin irritation
Gladskin of The Netherlands has won the prestigious Beauty Astir Award for Best Beauty Discovery of 2013. For 29 years, the Dutch Beauty press, 'BeautypersNL',has awarded the Beauty Astir Awards - an independent press award from a panel of 38 expert judges. Gladskin's revolutionary products have been developed for people with acne, rosacea, eczema and skin irritation. The effective and patented Staphefekt™ enzyme in Gladskin kills only Staphylococcus aureus bacteria, which cause the majority of all skin infections. It is the world's only product that leaves all good bacteria - essential for a healthy skin - intact. This marks a new era in the approach to skin problems.
The assessment of the panel of judges: "Gladskin has discovered that skin problems such as eczema, acne and rosaceacan be caused or aggravatedby particular bacteria. And they have found a wayto eliminate only these, without killing the healthyskin flora that is naturally present on every skin. Clearly Gladskin has been developed by great scientific minds. For people who have tried everything, Gladskin's targeted approachcanoffer a real solution. Pure, intelligent skincare, without any unneccesary additives, itdoes just what it's intended to do."
How Gladskin works
Many people suffer from skin problems such as rosacea, acne or eczema. Scientific research has demonstrated that Staphylococcus aureus (S. aureus) bacteria cause the majority of all skin infections and exacerbate many skin problems. In contrast to antibiotics and products containing acids and alcohol, with Gladskin, Micreos has developed the first product that targets only the S. aureus bacterium. As a result, Gladskin contributes to a healthy bacterial skin balance. This has turned out to be a significant breakthrough for many people with acne, eczema, rosacea and other skin irritations.
Mark Offerhaus, CEO Micreos: "We're very pleased with this recognition by an independent expert jury. People with acne, eczema, rosacea and skin irritation now have an extra tool to calm their skin. Many customers experience Gladskin as a real 'life changer'- and are keen to share their experience for the benefit of others. Thanks to our completely new approach the use of antibiotics can often be avoided. More products will be introduced in the course of 2014."
Micreos (http://www.micreos.com) is a Dutch biotechnology company specialised in the development of products against unwanted bacteria based on its phage technology. The company is regarded as a global leader in this field. Micreos Human Health collaborates with many top institutes, such as the Swiss Federal Technology Institute in Zurich and Erasmus Medical Centre in Rotterdam. Micreos Food Safety has also developed FDA approved products against Salmonella (SALMONELEX) and Listeria (LISTEX). Gladskin (http://www.gladskin.com) is a Micreos Human Health brand dedicated to the development of the best possible skin care products.
Aug. 26, 2016 09:15 PM EDT Reads: 1,421
Aug. 26, 2016 07:15 PM EDT Reads: 379
Aug. 26, 2016 07:00 PM EDT Reads: 642
Aug. 26, 2016 07:00 PM EDT Reads: 674
Aug. 26, 2016 06:00 PM EDT Reads: 1,915
Aug. 26, 2016 05:00 PM EDT Reads: 663
Aug. 26, 2016 04:45 PM EDT Reads: 1,525
Aug. 26, 2016 04:30 PM EDT Reads: 2,297
Aug. 26, 2016 04:00 PM EDT Reads: 3,927
Aug. 26, 2016 03:45 PM EDT Reads: 553
Aug. 26, 2016 03:15 PM EDT Reads: 414
Aug. 26, 2016 01:30 PM EDT Reads: 3,411
Aug. 26, 2016 01:00 PM EDT Reads: 1,974
Aug. 26, 2016 12:30 PM EDT Reads: 635
SYS-CON Events announced today that eCube Systems, a leading provider of middleware modernization, integration, and management solutions, will exhibit at @DevOpsSummit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. eCube Systems offers a family of middleware evolution products and services that maximize return on technology investment by leveraging existing technical equity to meet evolving business needs. ...
Aug. 26, 2016 11:45 AM EDT Reads: 584